News

"It's likely that every broker’s book of business contains groups where ICHRA could meet specific needs effectively,” the report said.

The American Diabetes Association has issued a guidance statement that cautions against using compounded versions of popular GLP-1 diabetes and weight-loss drugs such as Wegovy and Zepbound.

Karen DeSalvo hopes users will be comfortable, but not too comfortable, with new navigation tools.

Dr. Vin Gupta says same-day prescription delivery might increase the odds that patients will take their medicine.

The CEO of a next-gen PBM is not sure he'll like government efforts to rein in his giant competitors.

It’s a fair and reasonable ask of legislators to create parity of choice for retirement investors, regardless of who their employer is, according to collective trust provider Great Gray Trust Company.